Article info
PDFExtended report
Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts
- Correspondence to:
Dr J Westra
Department of Rheumatology, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, Netherlands; j.westramed.rug.nl
Citation
Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts
Publication history
- Accepted January 24, 2004
- First published October 12, 2004.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Annals of the Rheumatic Diseases